Perspectives in Neonatal Pharmacology: Drug Discovery, Knowledge Integration and Structured Prioritization

Curr Pharm Des. 2018;24(41):4839-4841. doi: 10.2174/138161282441190320125910.

Karel Allegaert^{1

2}, Anne Smits^{2

3}, Sinno Simons¹, John Van den Anker^{4

5

6}

¹ Department of Pediatrics, Division of Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, Netherlands.
² Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
³ Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
⁴ Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
⁵ Division of Clinical Pharmacology, Department of Pediatrics, Children's National Health System, Washington, DC, United States.
⁶ Division of Paediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.

No abstract available

MeSH terms